Company Overview and News

9
Philip Morris (PM) Q3 Earnings: Cigarette Woes Dim Prospects

2018-10-15 zacks
Philip Morris International Inc. (PM - Free Report) is slated to release third-quarter 2018 results on Oct 18, before the opening bell. The company has a mixed record of earnings surprises in the trailing four quarters. Let’s take a look at the factors that are likely to impact this tobacco giant’s upcoming quarterly announcement. Estimates for the Quarter The Zacks Consensus Estimate for third-quarter 2018 earnings is currently pegged at $1.
PM VGR BATS 4162 MO

1
Is Vector Group's Business Model Being Disrupted?

2018-10-08 seekingalpha
Vector Group (VGR) has appeal for those interested in a high dividend yield. The company has paid uninterrupted cash dividends for the past 23 years and annual 105-to-100 stock splits since 1999. For those who bought the stock near the end of the last recession the stock provided a 12.4% annualized return with dividends reinvested from August 31, 2008 to August 31, 2018 even after the stock price’s recent downturn.
VGR BATS 4162

12
Top 50 Russell Stocks Yield 7.4% To 17.5% In October

2018-10-05 seekingalpha
"All Russell US Indexes are subsets of the Russell 3000 Index, [namely] large-cap Russell 1000 & small-cap Russell 2000 Indexes. These Indexes are. building blocks of financial-products [and] performance-benchmarks."---ftserussell.com.
NYMTO ORC STWD.WI MITT NYMTP CIM GMRE AGNC WMC AJXA GOV PEGI NRZ DX GOVNI VGR SIR PEG NYMT STWD AJX

17
Wall Street Targets 90 Champions, Contenders, And Challengers As Dividend Stars For October

2018-10-03 seekingalpha
Champion dividend stocks sustain 25 or more annual dividend increases; Contenders show 10-24, Challengers have 5-9. WallStar selections all show .05% or higher price target upsides.
ENBBF NYSE PEGI TLP HMLP NRZ ENB EPD MDP SEP SRLP ENB EQM VGR PBFX SIR APU MDPEB SUN PEG EBBNF

5
VGR / Vector Group, Ltd. 8-K (Current Report)

2018-09-28 sec.gov - 4
Document
VGR

5
5 Dividend Achievers To Gain 16.9% To 32.2% By September 2019 Per Broker Targets

2018-09-27 seekingalpha - 2
Dividend Achiever stocks are distinguished by 10 or more straight years of higher dividends. Some 266 Achiever equities are balanced by sectors and capitalization. PFM is their tracking ETF.
HEP GIS TLP EPD SEP MCY TCP VGR APU WPC MMP OHI MO IVZ

28
50 Top Consumer Defensive Yield And Price Upsides Per Broker September Targets

2018-09-25 seekingalpha - 1
WallStars show positive broker target price upsides. Cresud SACIF topped the September consumer defensive WallStars analyst-estimated net gains as of 9/21/18.
PM BUD GIS BATS 4162 BIG NWL VGR KHC AHBIF BG BGS MO

19
Investments In The Booming Marijuana Sector, But Should You Dive In?

2018-09-21 seekingalpha - 3
The market for cannabis stocks is quite tumultuous and difficult to navigate. But just a year ago, options for ordinary retail investors were extremely limited; there were no ETFs to invest in, and most stocks were listed in Canada. But now, we have many choices as money has poured into stocks and funds in anticipation of Canada’s pending legalization of recreational cannabis on October 17 and growing speculation that other industries will buy in.
IMBBY PM MJ JAPAF UVV 2914 MJX UVVZP BATS 4162 ITYBF ACT CGC TLRY CMG VGR GWPH HMLSF JAPAY ETFC GWP IMBBF MO

2
What FDA's Stance on E-Cigarettes Means for Tobacco Stocks

2018-09-17 zacks
The e-cigarettes arena in the tobacco space has been in the spotlight since the past few days, thanks to FDA’s latest moves to curb the rave of such products among the youth. The FDA has issued a series of actions and directives for companies manufacturing e-cigarettes. In response to the recent legal enactments surrounding e-cigarettes, Altria (MO - Free Report) has applied for the review of smokeless tobacco product — Copenhagen Snuff.
IMBBY VGR JAPAF JAPAY 2914 BATS 4162 ITYBF IMBBF

14
The Zacks Analyst Blog Highlights: United States Gasoline, Invesco Dynamic Building & Construction, Materials Select Sector SPDR Fund and AdvisorShares VICE

2018-09-17 zacks
Chicago, IL – September 17, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include United States Gasoline ETF (UGA - Free Report) , Invesco Dynamic Building & Construction ETF (PKB - Free Report) , Materials Select Sector SPDR Fund (XLB - Free Report) and AdvisorShares VICE ETF (ACT - Free Report) .
HD PM VGR GNRC BECN BATS 4162 HRI HTZ CAR MO

18
Interactive Brokers - From Government Policy To Natural Catastrophe: Tobacco Stocks Face Mounting Challenges

2018-09-16 seekingalpha - 6
Pressure against U.S.-based tobacco companies has been building, amid ongoing trade disputes, the potential for stricter product regulation, as well as the likelihood of regional crop damage from Hurricane Florence.
STZ.B VGR WEED XLP AOI STZ PYX CGC

14
4 ETFs Set to Soar in the Aftermath of Hurricane Florence

2018-09-14 zacks
Hurricane Florence has wreaked havoc on the coast of the Carolinas where conditions are fast deteriorating. Florence, the first major hurricane to threaten the eastern United States this year, has now downgraded to a Category 1 storm. Still, it may lead to catastrophic flooding, life-threatening storm surge and destructive winds in Southeast U.S. over the weekend and into early next week. The damage caused by Hurricane Florence is unlikely to be like last year’s Harvey and Irma but could impact U.
HD PM KMX BECN BATS 4162 MAS HRI CAR VGR GNRC HTZ MO

2
Ladenburg - If You Have To Play

2018-09-13 seekingalpha - 1
Ladenburg's (non-executive) Chairman - and 35% direct owner - is being accused of a pump and dump scheme.
LTS-A VGR LTS

1
Altria (MO) Shares Up Close to 7% on FDA's Latest Notice

2018-09-13 zacks
The tobacco space grabbed the limelight after the FDA issued warnings regarding the sale of e-cigarettes to youths yesterday. The news was welcomed by investors of Altria Group, Inc. (MO - Free Report) , which saw its shares rally 6.7% in a single trading session. This took the Zacks Rank #3 (Hold) stock’s past three-month price performance to an increase of almost 12% against the industry’s dip of 1.
VGR BATS 4162 MO

14
No Blood In The Streets: Should You Still Invest In The Tobacco Sector

2018-09-10 seekingalpha - 2
Financial stability and profitability of Altria, Philip Morris International, Imperial Brands, British American Tobacco and Vector Group are critically assessed.
IMBBY PM BUD PE RAI BATS 4162 ITYBF EV VGR AHBIF FCF IMBBF MO

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to VGR / Vector Group, Ltd. on message board site Silicon Investor.

Covalent Group Inc (CVGR) an undiscovered CRO Covalent Group Inc (CVGR) an undiscovered CRO Covalent Group Inc (CVGR) an undiscovered CRO
CUSIP: 92240M108